Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Investigation of an enhancer-trap line exhibiting testis-specific
beta-galactosidase
expression led to the isolation of the Drosophila gene encoding
inosine monophosphate dehydrogenase
(
IMPD
), the rate-limiting enzyme in guanine nucleotide synthesis, which has been implicated in cell cycle control and malignant transformation. Northern and in situ hybridization analysis demonstrated that the gene has a complex expression pattern involving several independently regulated transcripts. Two ubiquitous, but highly ovary enriched, transcripts of 2.5 and 1.9 kb are expressed in the nurse cells and delivered to the oocyte, whilst a 0.9 kb transcript is found exclusively in the testis. The 2.5 kb transcript encodes a 58 kDa protein, which is highly similar in length and sequence to mouse and human IMPDs and is presumably required for GTP synthesis during early embryogenesis. Over-expression of this cDNA in Escherichia coli yielded a product of the predicted size, which was demonstrated to possess
IMPD
activity in a spectrophotometric assay. The coding capacity of the other transcripts is currently uncertain. We present evidence that
IMPD
is the product of the raspberry (ras) locus at 9E and the functions of the gene are discussed in relation to the phenotypes of ras mutants.
...
PMID:The raspberry locus encodes Drosophila inosine monophosphate dehydrogenase. 747 79